Monday, May 14, 2018

Tandem Diabetes Care upped to buy by Piper

Piper Jaffray upgraded Tandem Diabetes Care (NASDAQ: TNDM) from Neutral to Overweight with a price target of $13.00 (from $8.00).
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.